1132093-70-9

Basic information

• Product Name: Dasatinib-d8
• Synonyms: BMS-354825-d8;Dasatinib-d8;N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl-d8]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide
• CAS NO: 1132093-70-9
• Molecular Formula: C22H26ClN7O2S
• Molecular Weight: 488.00554
• Product Categories: Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Tyrosine Kinase Inhibitors;Isotope Labelled Compounds
• Mol File: 1132093-70-9.mol
• Article Data: 1

Chemical Properties

• Melting Point: 272-274°C
• Appearance: /
• Storage Temp.: -20?C Freezer
• Solubility: DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: Dasatinib-d8(CAS DataBase Reference)
• NIST Chemistry Reference: Dasatinib-d8(1132093-70-9)
• EPA Substance Registry System: Dasatinib-d8(1132093-70-9)

Safety Data

• Hazardous Substances Data: 1132093-70-9(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Uses

Different sources of media describe the Uses of 1132093-70-9 differently. You can refer to the following data:
1. A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic
2. A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. It is a COVID19-related research product.

Relevant articles and documents

HETEROCYCLIC KINASE INHIBITORS

This invention relates to novel 2-{6-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole-5-carboxylic acid (2-chloro-6-methyl-phenyl)-amide derivatives, and pharmaceutically acceptable acid addition salts thereof. The invention als